NCT07308717

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,896 (estimated)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
OTHER	Modification to Pre-operative Order Set	Modification to the pre-operative order set to remove gabapentin

Timeline

• Start date: 2025-12-16
• Primary completion: 2027-12-16
• Completion: 2027-12-16
• First posted: 2025-12-30
• Last updated: 2025-12-30

Locations

7 sites across 1 country: United States